photothermal 治疗(PTT ) 技术为癌症治疗被认为是一个有希望的方法。然而,阻止它的临床的申请的障碍之一是存在的 non-degradability 和 biotoxicity 重金属、基于碳的治疗学的代理人。因此,有高 photothermal 效率,低毒性,和好 biocompatibility 的 PTT 材料着急地被想要。此处,我们报导钛有为 PTT 过程的高功效和低毒性的基于氧化物的治疗学的代理人。我们表明了那 Magn
The photothermal therapy (PTT) technique is regarded as a promising method for cancer treatment. However, one of the obstacles preventing its clinical application is the non-degradability and biotoxicity of the existing heavy-metal and carbon-based therapeutic agents. Therefore, a PTT material with a high photothermal efficiency, low toxicity, and good biocompatibility is urgently wanted. Herein, we report a titanium oxide-based therapeutic agent with a high efficacy and low toxicity for the PTT process. We demonstrated that Magneliphase Ti8015 nanoparticles fabricated by the arc-melting method exhibit 〉98% absorption of near infrared light and a superior photothermal therapy effect in the in vivo mouse model. The Ti8O15 nanoparticle PTT material also shows a good biocompatibility and biosafety. Our study reveals Magneli-phase titanium oxide as a new family of PTT agents and introduces new applications of titanium oxides for photothermal conversion.